[Drugs interfering with platelet function].
Drugs interfering with platelet aggregation pathways and Ca2+ availability were reviewed. Particularly receptor antagonists, drugs affecting intracellular concentration of cAMP and drugs acting on enzymes involved in the synthesis of PGE2 and PGF2, thromboxane and PGI, were considered.
Marino
A
A
II Facoltà di Medicina e Chirurgia dell'Università di Napoli.
De Natale
G
G
D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors; D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology; D002118:Calcium / Q000037:antagonists & inhibitors / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D010972:Platelet Activating Factor; D010974:Platelet Aggregation / Q000187:drug effects* / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D011453:Prostaglandins / Q000096:biosynthesis; D011956:Receptors, Cell Surface / Q000187:drug effects
D001779:Blood Coagulation Factors; D010972:Platelet Activating Factor; D010975:Platelet Aggregation Inhibitors; D011453:Prostaglandins; D011956:Receptors, Cell Surface; D000242:Cyclic AMP; D002118:Calcium
Farmaci interferenti con la funzione piastrinica.